Lymphoma Symptoms in Adults
Latest News and Mantle Cell Lymphoma Life Expectancy related articles
B cell Lymphoma Prognosis: Patients with Diffuse large B cell lymphoma 5 year survival rate are 60%. Patients with Chronic lymphocytic lymphoma 5 year survival rate are 50%. Survival rate depends on early detection of B-cell lymphoma.
Lymphoma Symptoms in Adults: weight loss, Anorexia, Lymphadenopathy, Pruritus, Fatigue, Fever of unknown origin, Lack of appetite, Dyspnea, Night sweats and swelling.
Lymphoma Symptoms in Women: Fever of unknown origin (FUO), Weight loss, Drenching night sweats, Shortness of breath, Pruritus (Itchy skin), Feeling very tired.
Mantle Cell Lymphoma Life Expectancy related tags and keywords for more search
nhl treatment hodgkin's treatment, cell lymphoma life expectancy, lymphoma non-hodgkin's lymphoma breast, prostate cancer lung cancer, used to treat hodgkin's, mantle cell lymphoma treatment, b-cell subtypes of non-hodgkin's, cell lymphoma survival rate, bone marrow transplant, stem cell transplant, used to treat, large cell lymphoma, types of lymphoma, Mantle Cell Lymphoma Life Expectancy, cell lymphoma prognosis, bone marrow, hodgkin's disease, immune system,, mantle cell lymphoma prognosis, lymphatic system, t-cell lymphoma, b-cell lymphoma, her, men, can, use, age, cat, red, our, port, chemo, drug, chemotherapy, gene, plan, large, groups, mantle cell lymphoma survival rate
B cell Lymphoma Prognosis: Patients with Diffuse large B cell lymphoma 5 year survival rate are 60%. Patients with Chronic lymphocytic lymphoma 5 year survival rate are 50%. Survival rate depends on early detection of B-cell lymphoma.
Lymphoma Symptoms in Adults: weight loss, Anorexia, Lymphadenopathy, Pruritus, Fatigue, Fever of unknown origin, Lack of appetite, Dyspnea, Night sweats and swelling.
Lymphoma Symptoms in Women: Fever of unknown origin (FUO), Weight loss, Drenching night sweats, Shortness of breath, Pruritus (Itchy skin), Feeling very tired.
Mantle Cell Lymphoma Life Expectancy related tags and keywords for more search
nhl treatment hodgkin's treatment, cell lymphoma life expectancy, lymphoma non-hodgkin's lymphoma breast, prostate cancer lung cancer, used to treat hodgkin's, mantle cell lymphoma treatment, b-cell subtypes of non-hodgkin's, cell lymphoma survival rate, bone marrow transplant, stem cell transplant, used to treat, large cell lymphoma, types of lymphoma, Mantle Cell Lymphoma Life Expectancy, cell lymphoma prognosis, bone marrow, hodgkin's disease, immune system,, mantle cell lymphoma prognosis, lymphatic system, t-cell lymphoma, b-cell lymphoma, her, men, can, use, age, cat, red, our, port, chemo, drug, chemotherapy, gene, plan, large, groups, mantle cell lymphoma survival rate
Mantle Cell Lymphoma Life Expectancy: What is Mantel Cell Lymphoma? Mantle cell lymphoma (MCL) is one of the rarest of the non-Hodgkin's lymphomas (NHLs), comprising about 6% of NHL cases. It’s a subtype of B-cells or B-Lymphocyte lymphoma categorized under Non-Hodgkin's lymphoma.
Mantle cell lymphoma is not communicable. Comprising about 7% of the patients belonging in this category, it is commonly found in age groups above 60 years old. The cause is unknown and no inherited predisposition has been identified. This disease is quite dangerous because its tumor grows very fast and ends up affecting most of the organs. Patients with mantle cell lymphoma are rarely under 50 and women represent a little more than a quarter in the patients number.
This type of lymphoma is manifested by swollen; non-tender lymph nodes located in the throat, and can involve other nodes such as the ones located near the collar bone, the armpits, groin, and chests. During the development of the Mantle cell lymphoma the non-cancerous mantle centers also become invaded by cancerous cells. The malignant cells can also metastasize in the spleen and liver, giving the sensation of a full, distended abdomen. It essentially is an abnormal break and subsequent translocation in a gene that causes the cells to divide too early before becoming capable of helping to fight diseases.
Mantle cell lymphoma is not communicable. Comprising about 7% of the patients belonging in this category, it is commonly found in age groups above 60 years old. The cause is unknown and no inherited predisposition has been identified. This disease is quite dangerous because its tumor grows very fast and ends up affecting most of the organs. Patients with mantle cell lymphoma are rarely under 50 and women represent a little more than a quarter in the patients number.
This type of lymphoma is manifested by swollen; non-tender lymph nodes located in the throat, and can involve other nodes such as the ones located near the collar bone, the armpits, groin, and chests. During the development of the Mantle cell lymphoma the non-cancerous mantle centers also become invaded by cancerous cells. The malignant cells can also metastasize in the spleen and liver, giving the sensation of a full, distended abdomen. It essentially is an abnormal break and subsequent translocation in a gene that causes the cells to divide too early before becoming capable of helping to fight diseases.
Copyright 2011 AcuteLymphoblasticLeukemia.Org
AcuteLymphoblasticLeukemia.Org
Custom Search
Custom Search
Mantle cell lymphoma life expectancy
mantle cell lymphoma survival rate
Mantle Cell Lymphoma Life Expectancy and Treatment
The overall 5-year survival rate for Mantle cell lymphoma is generally 50 percent (for advanced stage Mantle cell lymphoma) to 70 percent (for limited stage Mantle cell lymphoma)
Mantle Cell Lymphoma Treatment
Diagnosis generally requires stained slides of a surgically removed part of a lymph node. The doctor widely uses Chemotherapy as frontline treatment, and often does not repeat to relapse due to side effects. The treatment for MCL is established depending on the type of MCL and it stage. Chemotherapy is one of the most destructive forms of treatment and it automatically assumes that the cancer cells are weaker than normal ones.
Alternate chemotherapy is sometimes used at first relapse. For frontline treatment, CHOP with rituximab (Mabthera ,Rituxan) is the most common chemotherapy, and often given as outpatient by IV. Another efficient treatment includes monoclonal antibodies such as Rituximab, usually used to treat Non-Hodgkin lymphoma and Mantle cell lymphoma as well. Using radiation therapy proved to be inefficient because it did not lead to a remarkably extinction of the cancer cells and it only weakened the human organism. A presentation at the December 2007 American Society of Hematology (ASH) conference showed that according to trial results, mantle cell lymphoma is potentially curable with very intensive chemo-immunotherapy followed by a stem cell transplant, when treated upon first presentation of the disease.
Mantle Cell Lymphoma Treatment
Diagnosis generally requires stained slides of a surgically removed part of a lymph node. The doctor widely uses Chemotherapy as frontline treatment, and often does not repeat to relapse due to side effects. The treatment for MCL is established depending on the type of MCL and it stage. Chemotherapy is one of the most destructive forms of treatment and it automatically assumes that the cancer cells are weaker than normal ones.
Alternate chemotherapy is sometimes used at first relapse. For frontline treatment, CHOP with rituximab (Mabthera ,Rituxan) is the most common chemotherapy, and often given as outpatient by IV. Another efficient treatment includes monoclonal antibodies such as Rituximab, usually used to treat Non-Hodgkin lymphoma and Mantle cell lymphoma as well. Using radiation therapy proved to be inefficient because it did not lead to a remarkably extinction of the cancer cells and it only weakened the human organism. A presentation at the December 2007 American Society of Hematology (ASH) conference showed that according to trial results, mantle cell lymphoma is potentially curable with very intensive chemo-immunotherapy followed by a stem cell transplant, when treated upon first presentation of the disease.